AFP and hepatocellular carcinoma: Alpha-fetoprotein (AFP), the most important tumor marker for HCC diagnosis, has been used for decades but results in a clinically unsatisfactory sensitivity of 40–65% and a specificity of 76–96% (Yanming et al., 2019).